MABPHARM LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.345 HKD | -.--% |
|
-.--% | -25.00% |
| Mar. 26 | Mabpharm Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Jan. 10 | Livzon Pharma Recognizes Credit, Asset Impairments | MT |
Quotes 5-day view
Delayed Quote Hong Kong S.E.| 2024-05-28 | 2024-05-29 | 2024-05-30 | 2024-05-31 | |
|---|---|---|---|---|
| Last | 0.345 $ | 0.345 $ | 0.345 $ | 0.345 $ |
| Volume | 0 | 94 000 | 0 | 0 |
| Change | -.--% | -.--% | -.--% | -.--% |
| Opening | 0.35 | 0.35 | 0.35 | 0.35 |
| High | 0.35 | 0.35 | 0.35 | 0.35 |
| Low | 0.35 | 0.34 | 0.35 | 0.35 |
Performance
| 1 month | -13.75% | ||
| 3 months | -28.12% | ||
| 6 months | -29.59% | ||
| Current year | -25.00% | ||
| 1 year | -33.65% | ||
| 3 years | -71.01% | ||
| 5 years | -71.49% |
Volumes
marketsDaily volume
0
Estimated daily volume
0
Avg. Volume 20 sessions
14 429
Daily volume ratio
0.00
Avg. Volume 20 sessions HKD
4 978.01
Avg. Volume 20 sessions USD
636.68
Record volume 1
167 506 000
Record volume 2
91 768 000
Record volume 3
56 694 500
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (HKD)
1 317 485 181
Capitalization (USD)
181 940 751
Net sales (CNY)
87 161 000
Net sales (USD)
12 036 673
Number of employees
347
Sales / Employee (CNY)
251 184
Sales / Employee (USD)
34 688
Free-Float
22.82 %
Free-Float capitalization (HKD)
300 696 467
Free-Float capitalization (USD)
41 525 280
Average Daily Capital Traded
0%
Highs and lows
1 week
0.34
0.35
1 month
0.300.40
Current year
0.250.50
1 year
0.250.79
3 years
0.251.40
5 years
0.251.80
10 years
0.251.80
Indicators
Moving average 5 days
0.35
Moving average 20 days
0.37
Moving average 50 days
0.42
Moving average 100 days
0.43
Price spread / (MMA5)
-.--%
Price spread / (MMA20)
+7.04%
Price spread / (MMA50)
+22.58%
Price spread / (MMA100)
+23.88%
STIM
RSI 9 days
18.00
RSI 14 days
22.24
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -.--% | -.--% | -25.00% | -33.65% | 182M | ||
| +2.77% | -0.35% | +11.91% | +40.72% | 118B | ||
| +1.06% | -0.49% | +11.60% | +33.25% | 106B | ||
| +1.87% | +3.76% | -4.68% | -4.26% | 24.28B | ||
| +1.04% | +0.89% | -0.82% | -6.56% | 21.96B | ||
| +0.31% | +0.55% | -10.12% | -28.92% | 18.16B | ||
| +0.41% | -1.50% | -42.12% | -35.22% | 16.37B | ||
| -3.50% | -2.53% | -17.47% | -32.63% | 15.56B | ||
| -0.91% | -2.86% | +2.77% | +51.25% | 13.63B | ||
| +4.28% | +5.12% | +34.58% | +5.00% | 12.27B | ||
| -3.39% | +150.23% | +77.64% | +189.28% | 8.87B | ||
| -7.66% | -3.38% | -33.51% | -37.65% | 7.29B | ||
| -1.71% | +3.60% | +7.26% | +55.34% | 7.75B | ||
| -20.47% | +156.95% | +232.76% | +432.82% | 6.1B | ||
| +0.09% | +2.20% | +11.89% | +41.90% | 7.65B | ||
| +0.25% | -1.43% | -3.92% | +24.97% | 7.42B | ||
| Average | -1.60% | +19.47% | +15.80% | +43.48% | ||
| Weighted average by Cap. | +0.72% | +5.89% | +9.70% | +31.16% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -25.00% | ||
| 2023 | +5.75% | ||
| 2022 | -56.50% | ||
| 2021 | -4.76% | ||
| 2020 | -8.70% | ||
| 2019 | -4.96% |
- Stock Market
- Equities
- 2181 Stock
- Quotes Mabpharm Limited
